Total Payments
$1,600
2024 Payments
$353.54
Companies
17
Transactions
34
Medicare Patients
538
Medicare Billing
$204,626
Payment Breakdown by Category
Food & Beverage$1,324 (82.8%)
Education$275.98 (17.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,324 | 31 | 82.8% |
| Education | $275.98 | 3 | 17.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $409.39 | 8 | $0 (2024) |
| Lilly USA, LLC | $205.86 | 3 | $0 (2024) |
| BOSTON SCIENTIFIC CORPORATION | $151.20 | 2 | $0 (2018) |
| Fresenius USA Marketing, Inc. | $137.59 | 2 | $0 (2019) |
| Mallinckrodt Hospital Products Inc. | $136.68 | 2 | $0 (2023) |
| Mallinckrodt Enterprises LLC | $99.00 | 1 | $0 (2019) |
| Amgen Inc. | $86.74 | 3 | $0 (2018) |
| Bayer Healthcare Pharmaceuticals Inc. | $77.35 | 1 | $0 (2024) |
| Eli Lilly Export S.A. Puerto Rico Branch | $53.56 | 3 | $0 (2024) |
| Medtronic Vascular, Inc. | $46.71 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $353.54 | 10 | Lilly USA, LLC ($139.38) |
| 2023 | $373.11 | 8 | AstraZeneca Pharmaceuticals LP ($133.99) |
| 2022 | $240.90 | 4 | AstraZeneca Pharmaceuticals LP ($217.11) |
| 2021 | $111.59 | 3 | Mallinckrodt Hospital Products Inc. ($76.99) |
| 2019 | $236.59 | 3 | Fresenius USA Marketing, Inc. ($137.59) |
| 2018 | $99.98 | 2 | BOSTON SCIENTIFIC CORPORATION ($76.41) |
| 2017 | $184.67 | 4 | BOSTON SCIENTIFIC CORPORATION ($74.79) |
All Payment Transactions
34 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Eli Lilly Export S.A. Puerto Rico Branch | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $12.59 | General |
| Category: Diabetes | ||||||
| 09/23/2024 | Eli Lilly Export S.A. Puerto Rico Branch | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $5.97 | General |
| Category: Diabetes | ||||||
| 09/12/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/23/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $45.10 | General |
| Category: IMMUNOLOGY | ||||||
| 07/29/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 06/29/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $77.35 | General |
| Category: Cardio-renal | ||||||
| 04/25/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/11/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $70.88 | General |
| Category: Diabetes | ||||||
| 03/26/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 02/22/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | Cash or cash equivalent | $68.50 | General |
| Category: Obesity | ||||||
| 12/14/2023 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/21/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $111.25 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/26/2023 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $28.26 | General |
| 08/24/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $59.69 | General |
| Category: IMMUNOLOGY | ||||||
| 08/24/2023 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $33.16 | General |
| 05/04/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $66.48 | General |
| Category: Diabetes | ||||||
| 02/23/2023 | Bayer Puerto Rico Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: Cardio-renal | ||||||
| 02/16/2023 | Eli Lilly Export S.A. Puerto Rico Branch | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: Diabetes | ||||||
| 11/09/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $97.50 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/28/2022 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Education | In-kind items and services | $99.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/11/2022 | Medtronic, Inc. | MICRA (Device) | Food and Beverage | In-kind items and services | $23.79 | General |
| Category: Pacemakers | ||||||
| 04/21/2022 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/04/2021 | PBG PUERTO RICO LLC | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/15/2021 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Education | In-kind items and services | $76.99 | General |
| Category: IMMUNOLOGY | ||||||
| 05/21/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 38 | 84 | $9,088 | $6,426 |
| 2022 | 4 | 63 | 153 | $29,331 | $22,408 |
| 2021 | 6 | 121 | 336 | $53,080 | $41,171 |
| 2020 | 9 | 316 | 1,465 | $171,858 | $134,621 |
Total Patients
538
Total Services
2,038
Medicare Billing
$204,626
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 14 | 32 | $3,509 | $2,384 | 67.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 13 | 39 | $2,893 | $2,268 | 78.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 11 | 13 | $2,687 | $1,774 | 66.0% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 12 | 65 | $18,754 | $14,812 | 79.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 21 | 25 | $5,167 | $3,617 | 70.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 18 | 43 | $3,189 | $2,430 | 76.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 12 | 20 | $2,222 | $1,549 | 69.7% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 25 | 85 | $24,524 | $19,334 | 78.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 26 | 41 | $8,473 | $6,419 | 75.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 21 | 105 | $7,788 | $6,047 | 77.6% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2021 | 18 | 20 | $4,856 | $3,885 | 80.0% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2021 | 14 | 53 | $3,929 | $3,111 | 79.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 17 | 32 | $3,509 | $2,375 | 67.7% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2020 | 68 | 279 | $80,497 | $63,739 | 79.2% |
| 90966 | Home dialysis services per month, patient 20 years of age or older | Office | 2020 | 15 | 108 | $26,145 | $20,621 | 78.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 56 | 267 | $19,803 | $15,646 | 79.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 57 | 84 | $17,359 | $13,305 | 76.6% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2020 | 29 | 43 | $10,440 | $8,167 | 78.2% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2020 | 39 | 109 | $8,081 | $6,366 | 78.8% |
| 90970 | Dialysis services, per day (less than full month service), patient 20 years of age or older | Office | 2020 | 14 | 516 | $4,087 | $3,254 | 79.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 18 | 30 | $3,290 | $2,164 | 65.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 20 | 29 | $2,155 | $1,359 | 63.1% |
About Dr. Cesar Rivera, MD
Dr. Cesar Rivera, MD is a Nephrology healthcare provider based in Arecibo, Puerto Rico. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1386749620.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Cesar Rivera, MD has received a total of $1,600 in payments from pharmaceutical and medical device companies, with $353.54 received in 2024. These payments were reported across 34 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($1,324).
As a Medicare-enrolled provider, Rivera has provided services to 538 Medicare beneficiaries, totaling 2,038 services with total Medicare billing of $204,626. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Arecibo, PR
- Active Since 09/13/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1386749620
Products in Payments
- ACTHAR (Biological) $235.68
- FARXIGA (Drug) $223.73
- MOUNJARO (Drug) $155.92
- BRILINTA (Drug) $99.99
- Kerendia (Drug) $93.88
- Parsabiv (Biological) $86.74
- LOKELMA (Drug) $85.67
- AMS (Device) $76.41
- WATCHMAN (Device) $74.79
- ZEPBOUND (Drug) $68.50
- HawkOne (Device) $46.71
- BENLYSTA (Biological) $45.10
- TRULICITY (Drug) $35.00
- PURIFIED CORTROPHIN GEL (Drug) $29.84
- MICRA (Device) $23.79
- ELIQUIS (Drug) $19.62
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.